Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novametrix Medical Systems was a prominent medical technology company specializing in the development and manufacturing of non-invasive patient monitoring systems. The company's core expertise lay in respiratory monitoring technologies, including capnography, pulse oximetry, and transcutaneous gas monitoring. These tools were critical for assessing patient ventilation and oxygenation in environments such as intensive care units, operating rooms, and neonatal wards. Novametrix was recognized for its innovation in sensor technology and its ability to provide reliable real-time clinical data. In 2002, the company was acquired by Respironics, Inc., which significantly expanded its respiratory monitoring portfolio. Following the subsequent acquisition of Respironics by Philips in 2008, Novametrix's technologies were integrated into the Philips Healthcare ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novametrix Medical Systems.